Epigenetic Reprogramming of the Type III Interferon Response Potentiates Antiviral Activity and Suppresses Tumor Growth

Open Access

Peer-reviewed

Research Article

Siyuan Ding,

Affiliations Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Microbiology Graduate Program, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
William Khoury-Hanold,

Affiliation Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Akiko Iwasaki,

Affiliations Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Michael D. Robek

* E-mail: michael.robek@yale.edu

Affiliation Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯

Reader Comments (0)

DNA methylation
Is the Subject Area "DNA methylation" applicable to this article?

Thanks for your feedback.
Astrocytes
Is the Subject Area "Astrocytes" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Chromatin
Is the Subject Area "Chromatin" applicable to this article?

Thanks for your feedback.
Interferons
Is the Subject Area "Interferons" applicable to this article?

Thanks for your feedback.
Histones
Is the Subject Area "Histones" applicable to this article?

Thanks for your feedback.
Vesicular stomatitis virus
Is the Subject Area "Vesicular stomatitis virus" applicable to this article?

Thanks for your feedback.